British Journal of Cancer - Table of Contents alert Volume 111 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 111, Issue 1 (1-212) Published online 8 July 2014 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Outlook Cancer Cancer kills millions of people across the globe every year. But the development of targeted medicines, novel drug delivery technologies and clinical research data offer a glimpse towards a cancer-free future.  Access the Outlook free online for six months.  Produced with support from Celgene Corporation. Clinical Studies Top Improving decision making about clinical trial participation – a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial I Juraskova, P Butow, C Bonner, M L Bell, A B Smith, M Seccombe, F Boyle, L Reaby, J Cuzick and J F Forbes Br J Cancer 2014 111: 1-7; advance online publication, June 3, 2014; 10.1038/bjc.2014.144 Abstract | Full Text Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial J F Christensen, L W Jones, A Tolver, L W Jørgensen, J L Andersen, L Adamsen, P Højman, R H Nielsen, M Rørth and G Daugaard Br J Cancer 2014 111: 8-16; advance online publication, May 27, 2014; 10.1038/bjc.2014.273 Abstract | Full Text Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial C Le Tourneau, X Paoletti, N Servant, I Bièche, D Gentien, T Rio Frio, A Vincent-Salomon, V Servois, J Romejon, O Mariani, V Bernard, P Huppe, G Pierron, F Mulot, C Callens, J Wong, C Mauborgne, E Rouleau, C Reyes, E Henry, Q Leroy, P Gestraud, P La Rosa, L Escalup, E Mitry, O Trédan, J-P Delord, M Campone, A Goncalves, N Isambert, C Gavoille and M Kamal Br J Cancer 2014 111: 17-24; advance online publication, April 24, 2014; 10.1038/bjc.2014.211 Abstract | Full Text Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab E Zulato, F Bergamo, A De Paoli, G Griguolo, G Esposito, G L De Salvo, C Mescoli, M Rugge, M Nardin, L Di Grazia, S Lonardi, S Indraccolo and V Zagonel Br J Cancer 2014 111: 25-32; advance online publication, June 3, 2014; 10.1038/bjc.2014.274 Abstract | Full Text Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data J Bohlius, T Tonia, E Nüesch, P Jüni, M F Fey, M Egger and J Bernhard Br J Cancer 2014 111: 33-45; advance online publication, April 17, 2014; 10.1038/bjc.2014.171 Abstract | Full Text COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment D Generali, F M Buffa, S Deb, M Cummings, L E Reid, M Taylor, D Andreis, G Allevi, G Ferrero, D Byrne, M Martinotti, A Bottini, A L Harris, S R Lakhani and S B Fox Br J Cancer 2014 111: 46-54; advance online publication, May 29, 2014; 10.1038/bjc.2014.236 Abstract | Full Text C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients K T Troppan, K Schlick, A Deutsch, T Melchardt, A Egle, T Stojakovic, C Beham-Schmid, L Weiss, D Neureiter, K Wenzl, R Greil, P Neumeister and M Pichler Br J Cancer 2014 111: 55-60; advance online publication, May 29, 2014; 10.1038/bjc.2014.277 Abstract | Full Text Translational Therapeutics Top Molecular targets of aspirin and cancer prevention L Alfonso, G Ai, R C Spitale and G J Bhat Br J Cancer 2014 111: 61-67; advance online publication, May 29, 2014; 10.1038/bjc.2014.271 Abstract | Full Text A novel decoy receptor fusion protein for FGF-2 potently inhibits tumour growth D Li, X Wei, K Xie, K Chen, J Li and J Fang Br J Cancer 2014 111: 68-77; advance online publication, May 29, 2014; 10.1038/bjc.2014.282 Abstract | Full Text High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors H Engerud, I L Tangen, A Berg, K Kusonmano, M K Halle, A M Øyan, K H Kalland, I Stefansson, J Trovik, H B Salvesen and C Krakstad Br J Cancer 2014 111: 78-84; advance online publication, May 22, 2014; 10.1038/bjc.2014.262 Abstract | Full Text Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation G Cheng, J Zielonka, D McAllister, S Tsai, M B Dwinell and B Kalyanaraman Br J Cancer 2014 111: 85-93; advance online publication, May 27, 2014; 10.1038/bjc.2014.272 Abstract | Full Text Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples M J Patterson, R E Sutton, I Forrest, R Sharrock, M Lane, A Kaufmann, R O'Donnell, R J Edmondson, B T Wilson and N J Curtin Br J Cancer 2014 111: 94-100; advance online publication, May 27, 2014; 10.1038/bjc.2014.261 Abstract | Full Text BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt I Pal, S Sarkar, S Rajput, K K Dey, S Chakraborty, R Dash, S K Das, D Sarkar, E Barile, S K De, M Pellecchia, P B Fisher and M Mandal Br J Cancer 2014 111: 101-111; advance online publication, June 3, 2014; 10.1038/bjc.2014.227 Abstract | Full Text Molecular Diagnostics Top TBLR1 is a novel prognostic marker and promotes epithelial–mesenchymal transition in cervical cancer J Wang, J Ou, Y Guo, T Dai, X Li, J Liu, M Xia, L Liu and M He Br J Cancer 2014 111: 112-124; advance online publication, May 29, 2014; 10.1038/bjc.2014.278 Abstract | Full Text Connexins and cyclooxygenase-2 crosstalk in the expression of radiation-induced bystander effects Y Zhao, S M de Toledo, G Hu, T K Hei and E I Azzam Br J Cancer 2014 111: 125-131; advance online publication, May 27, 2014; 10.1038/bjc.2014.276 Abstract | Full Text Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver adenomas Y Singh, J Port, M Schwarz and A Braeuning Br J Cancer 2014 111: 132-138; advance online publication, May 29, 2014; 10.1038/bjc.2014.275 Abstract | Full Text Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism M Donet, S Brassart-Pasco, S Salesse, F-X Maquart and B Brassart Br J Cancer 2014 111: 139-148; advance online publication, May 29, 2014; 10.1038/bjc.2014.239 Abstract | Full Text Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells J Kraan, P van den Broek, C Verhoef, D J Grunhagen, W Taal, J W Gratama and S Sleijfer Br J Cancer 2014 111: 149-156; advance online publication, June 3, 2014; 10.1038/bjc.2014.286 Abstract | Full Text The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer F J A Gujam, J Edwards, Z M A Mohammed, J J Going and D C McMillan Br J Cancer 2014 111: 157-165; advance online publication, May 29, 2014; 10.1038/bjc.2014.279 Abstract | Full Text AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial S Gnosa, H Zhang, V P Brodin, J Carstensen, G Adell and X-F Sun Br J Cancer 2014 111: 166-173; advance online publication, May 29, 2014; 10.1038/bjc.2014.250 Abstract | Full Text Epidemiology Top Prognostic value of ABO blood group in patients with surgically resected colon cancer X Cao, Z-S Wen, Y-J Sun, Y Li, L Zhang and Y-J Han Br J Cancer 2014 111: 174-180; advance online publication, June 5, 2014; 10.1038/bjc.2014.302 Abstract | Full Text Diabetes and pancreatic cancer survival: a prospective cohort-based study A T Toriola, R Stolzenberg-Solomon, L Dalidowitz, D Linehan and G Colditz Br J Cancer 2014 111: 181-185; advance online publication, May 1, 2014; 10.1038/bjc.2014.224 Abstract | Full Text Long-term alcohol intake and risk of endometrial cancer in the Nurses’ Health Study, 1980–2010 Y Je, I DeVivo and E Giovannucci Br J Cancer 2014 111: 186-194; advance online publication, May 22, 2014; 10.1038/bjc.2014.257 Abstract | Full Text The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer L Ellis, M P Coleman and B Rachet Br J Cancer 2014 111: 195-202; advance online publication, May 22, 2014; 10.1038/bjc.2014.217 Abstract | Full Text Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities D Reinau, C Surber, S S Jick and C R Meier Br J Cancer 2014 111: 203-206; advance online publication, May 29, 2014; 10.1038/bjc.2014.265 Abstract | Full Text Childhood body mass index and the risk of prostate cancer in adult men J Aarestrup, M Gamborg, M B Cook, T I A Sørensen and J L Baker Br J Cancer 2014 111: 207-212; advance online publication, May 27, 2014; 10.1038/bjc.2014.266 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.